Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tremlett, H.
Right arrow Articles by Devonshire, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tremlett, H.
Right arrow Articles by Devonshire, V.
Related Collections
Right arrow Prognosis
Right arrow Multiple sclerosis
Right arrowRelated Article
NEUROLOGY 2006;66:172-177
© 2006 American Academy of Neurology

Disability progression in multiple sclerosis is slower than previously reported

Helen Tremlett, PhD, Donald Paty, MD{dagger} and Virginia Devonshire, MD

From the Department of Medicine (Neurology [H.T., D.P., V.D.] and Health Care and Epidemiology [H.T.]), University of British Columbia, Vancouver, Canada.

Address correspondence and reprint requests to Dr. Helen Tremlett, Department of Medicine (Neurology), Rm. S159, 2211 Wesbrook Mall, University of British Columbia, Vancouver, BC V6T 2B5, Canada; e-mail: tremlett{at}interchange.ubc.ca

Objective: To investigate disease progression and risk factors in a large geographically based population with multiple sclerosis (MS), using two different inception points—clinical onset and date of birth.

Methods: The authors reviewed a database of subjects with definite MS and symptom onset prior to July 1988. The main outcome was sustained progression to Expanded Disability Status Scale (EDSS) 6 (requires a cane), using the date of birth and date of MS onset as inception points in separate analyses. Risk factors examined were sex, relapsing vs primary progressive course, onset age, and onset symptoms.

Results: The study included 2,837 patients, followed prospectively for 22,723 patient years. The median time to EDSS 6 was 27.9 years, 15 years after onset; only 21% reached EDSS 6, and by age 50, 28% required a cane. Men progressed 38% more quickly than women from onset (p < 0.0005), yet both required canes at similar ages: 58.8 years for men and 60.1 for women (p = 0.082). A younger onset age predicted a slower progression, but those older at onset were consistently older when reaching EDSS 6. A primary progressive course predicted a more rapid progression from both onset (p < 0.0005) and birth (hazard ratio = 2.7 [95% CI: 2.2 to 3.3]). No onset symptom consistently predicted progression.

Conclusion: Disability progression in multiple sclerosis (MS) accrued more slowly than found in earlier longitudinal studies. The authors also challenged two fundamental concepts in MS, demonstrating that neither male sex nor older onset age was associated with worse disease outcome.


Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the January 24 issue to find the title link for this article.

Commentary, see page 157

{dagger}Deceased.

Helen Tremlett is funded by a "Don Paty Career Development Award" from the MS Society of Canada, the Michael Smith Foundation for Health Research, and the Christopher Foundation. The BC-wide MS database was funded by an unrestricted grant from Don Paty and the MS/MRI research group. This analysis was funded by a grant from the MS Society of Canada.

Disclosure: The authors report no conflicts of interest.

Received May 11, 2005. Accepted in final form October 11, 2005.


Related Article

January 24 Highlight and Commentary: Therapeutic decision making in MS: Impact of a slower disability progression
Neurology 2006 66: 157. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
H Tremlett, Y Zhao, J Joseph, V Devonshire, and the UBCMS Clinic Neurologists*
Relapses in multiple sclerosis are age- and time-dependent
J. Neurol. Neurosurg. Psychiatry, December 1, 2008; 79(12): 1368 - 1374.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
N Grytten Torkildsen, S. Lie, J. Aarseth, H Nyland, and K. Myhr
Survival and cause of death in multiple sclerosis: results from a 50-year follow-up in Western Norway
Multiple Sclerosis, November 1, 2008; 14(9): 1191 - 1198.
[Abstract] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
C Hirst, G Ingram, R Swingler, D A S Compston, T Pickersgill, and N P Robertson
Change in disability in patients with multiple sclerosis: a 20-year prospective population-based analysis
J. Neurol. Neurosurg. Psychiatry, October 1, 2008; 79(10): 1137 - 1143.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
C Confavreux, C Ritleng, M Debouverie, F Durand-Dubief, R Marignier, G Androdias, L Laforest, E van Ganse, and S Vukusic
Defining the natural history of multiple sclerosis: the need for complete data and rigorous definitions. Answer to Dr Tremlett et al.
Multiple Sclerosis, September 1, 2008; 14(8): 1144 - 1147.
[PDF]


Home page
Mult SclerHome page
H. Tremlett, Y. Zhao, and V. Devonshire
Defining the natural history of MS: the need for complete data and rigorous definitions
Multiple Sclerosis, September 1, 2008; 14(8): 1142 - 1143.
[PDF]


Home page
Mult SclerHome page
V. Mark, E Taub, K Bashir, G Uswatte, A Delgado, M. Bowman, C. Bryson, S McKay, and G. Cutter
Constraint-Induced Movement therapy can improve hemiparetic progressive multiple sclerosis. Preliminary findings
Multiple Sclerosis, August 1, 2008; 14(7): 992 - 994.
[Abstract] [PDF]


Home page
Mult SclerHome page
M Koch, J De Keyser, and H Tremlett
Timing of birth and disease progression in multiple sclerosis
Multiple Sclerosis, July 1, 2008; 14(6): 793 - 798.
[Abstract] [PDF]


Home page
Mult SclerHome page
A. Miller, V. Spada, D. Beerkircher, and R. R. Kreitman
Long-term (up to 22 years), open-label, compassionate-use study of glatiramer acetate in relapsing--remitting multiple sclerosis
Multiple Sclerosis, May 1, 2008; 14(4): 494 - 499.
[Abstract] [PDF]


Home page
Mult SclerHome page
C. Confavreux
Defining the natural history of MS: the need for complete data and rigorous definitions
Multiple Sclerosis, April 1, 2008; 14(3): 289 - 291.
[PDF]


Home page
Mult SclerHome page
H. Tremlett, Yinshan Zhao, and V. Devonshire
Natural history of secondary-progressive multiple sclerosis
Multiple Sclerosis, April 1, 2008; 14(3): 314 - 324.
[Abstract] [PDF]


Home page
Mult SclerHome page
M. Koch, M. Uyttenboogaart, M. Heerings, D. Heersema, J. Mostert, and J. De Keyser
Progression in familial and nonfamilial MS
Multiple Sclerosis, April 1, 2008; 14(3): 300 - 306.
[Abstract] [PDF]


Home page
NeurologyHome page
M. G. Brown, S. Kirby, C. Skedgel, J. D. Fisk, T. J. Murray, V. Bhan, and I. S. Sketris
How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?
Neurology, October 9, 2007; 69(15): 1498 - 1507.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. A. Gauthier, M. Mandel, C.R.G. Guttmann, B. I. Glanz, S. J. Khoury, R. A. Betensky, and H. L. Weiner
Predicting short-term disability in multiple sclerosis
Neurology, June 12, 2007; 68(24): 2059 - 2065.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
J.A. Woolmore, M. Stone, E.M. Pye, J.M. Partridge, M. Boggild, C. Young, P.W. Jones, A.A. Fryer, C.P. Hawkins, and R.C. Strange
Studies of associations between disability in multiple sclerosis, skin type, gender and ultraviolet radiation
Multiple Sclerosis, April 1, 2007; 13(3): 369 - 375.
[Abstract] [PDF]


Home page
NeurologyHome page
A.-L. Sayao, V. Devonshire, and H. Tremlett
Longitudinal follow-up of "benign" multiple sclerosis at 20 years
Neurology, February 13, 2007; 68(7): 496 - 500.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
H. Tremlett and V. Devonshire
Is late-onset multiple sclerosis associated with a worse outcome?
Neurology, September 26, 2006; 67(6): 954 - 959.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by AAN Enterprises, Inc.